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An I for editing
In vitro editing in mammalian nuclear extracts
reveals adenosine-to-inosine conversions in
glutamate receptor messenger RNAs.
The discovery of RNA editing, almost a decade ago,
brought a new twist to the familiar tale of how genetic
information flows from DNA to protein. RNA editing
involves the insertion, deletion or substitution of nucleo-
tides within nascent RNA transcripts, and produces
RNA molecules with sequences that differ from those
encoded genomically (reviewed in [1]). RNA editing can
alter the encoded open reading frame of a messenger
(m)RNA, or produce non-encoded nucleotides required
for ribosomal (r) and transfer (t) RNAs to fold into their
correct native structures. Most examples of RNA editing
have been found in organelle-encoded RNAs, and the
large number of these examples has made researchers
studying organelle processes cautious in assuming that
a cDNA sequence corresponds to that of its gene.
Researchers studying nuclear-encoded RNAs have not
adopted this cautious approach, because few examples of
edited nuclear-encoded RNAs have'been reported. The
nuclear-encoded RNAs for which editing has been
observed are all mammalian and include apolipoprotein
B mRNA, several glutamate receptor (gluR) mRNAs
and the Wilms' tumor susceptibility gene mRNA (see [2]
and references cited in [1]).
Current studies of the different types of RNA editing are
mostly focused on identifying the cellular factors that
catalyze editing in vivo. In contrast to the hardships
usually encountered during the search for such factors,
even at its first report in 1991 [3], the characteristics of
gluR mRNA editing suggested that the enzyme res-
ponsible may already be known. Editing within gluR
mRNAs occurs at sites of genomic adenosines which,
after editing, appear as guanosines in cDNAs. The ob-
served A to G transitions are consistent with the action of
a previously characterized enzyme known as double-
stranded RNA (dsRNA) adenosine deaminase (dsRAD).
The enzyme dsRAD deaminates adenosines within
dsRNA to produce inosines and was discovered rather
serendipitously in 1987, when a synthetic dsRNA was
injected into the cytoplasm of Xenopus embryos (see cita-
tions in [1]). As inosine, like guanosine, prefers to pair with
cytidine, inosines within an RNA appear as guanosines in
cDNAs, as observed for the gluR mRNAs. Over the
years, dsRAD activity has been detected in organisms
throughout the animal kingdom, including mammals, but
it has remained an enzyme in search of a function.
The RNA transcripts for several different gluR subunits
are edited, and multiple editing sites can occur within a
single gluR mRNA [4,5]. Although not all of the editing
events appear to be functionally relevant, some produce
codon changes that clearly alter the properties of the ion
channels assembled from the gluR subunits. One of the
functionally important editing sites - the Q/R site -
converts a glutamine (Q) codon to an arginine (R) codon
within mRNAs encoding subunits B, 5 and 6 [3,5], while
another - the R/G site - converts an arginine (R) to a
glycine (G) within mRNAs for subunits B, C and D [6].
Further support for a role for dsRAD in gluR mRNA
editing came in 1993, when Seeburg and colleagues [5]
showed editing at the Q/R site of gluR-B RNA requires
base-pairing between the surrounding exon sequences
and the downstream intron. The unspliced RNA is pre-
dicted to form a double-stranded structure, periodically
interrupted by internal loops, mismatches and bulges (see
Fig. 1). More recently, Seeburg's laboratory [6] identified
the R/G site mentioned above and showed that this edit-
ing event is also dependent on a structure that is largely
double-stranded.
Three recent reports [7-9] provide further evidence for
the involvement of dsRAD in gluR RNA editing. These
reports, one a collaborative effort by the laboratories of
Tom Maniatis and Richard Axel [7], another by Ron
Emeson and colleagues [8], and the third a collaboration
between the laboratories of Walter Keller and Peter
Seeburg [9], all demonstrate that gluR transcripts synthe-
sized in vitro can be correctly edited when incubated with
mammalian nuclear extracts. Most importantly, all three
groups present clear evidence that editing in vitro involves
the conversion of adenosines to inosines. Consistent with
the characteristics of dsRAD determined in vitro with syn-
thetic substrates (see citations in [1]), editing of gluR RNA
in these in vitro systems does not require the addition of
cofactors, is sensitive to proteinase K and requires the
dsRNA structure predicted to surround the editing sites.
All three groups show that in vitro editing of gluR RNA
can be competed with various dsRNAs, as expected if
dsRAD is responsible for the editing. Two of the reports
[7,8] also show that gluR-B RNA competes for its own
editing better than a synthetic dsRNA designed to form
a completely base-paired structure. This latter result
should be treated cautiously, as it is not clear if the vari-
ous dsRNA competitors have the same number of bind-
ing sites for the editing enzyme, whether the substrate
inhibition characteristic of dsRAD is operating [10], or
just how many other dsRNA-binding proteins exist in
© Current Biology 1995, Vol 5 No 6598
. SS RNA EDITING
DISPATCH 599
Fig. 1. A hypothetical structure encompassing the Q/R site, and showing additional editing sites mapped within endogenous rat [8] and
mouse [5] glutamate receptor RNAs. The height of the green bars is relative to the number of rat cDNAs that contained a particular A to
G transition, with sites represented in s 10% of the population indicated with green asterisks and exact percentages indicated for edit-
ing hot spots. Only editing hot spots are shown for the mouse sequence (red dots). Blue letters indicate nucleotides encoded by the
mouse gene that differ from those of the rat (as detailed in [8]). The secondary structure has not been confirmed, but the helices shown
are supported by compensatory mutations at all nucleotides paired with an orange line (see [5,7,8]). Little information is available
regarding the structure of the sequences shown as unpaired (surrounding the question mark). All editing sites shown are in intron
sequences except for the Q/R site and the adjacent site, the editing of which results in a silent codon change.
the crude extracts. These cautions aside, however, an
interesting interpretation of these data is that dsRAD has
a particular high affinity for the native, intramolecular
gluR-B RNA structure.
The paper by Yang et al. [7] also reports that the sites of
in vitro editing in gluR-B RNA are different from those
found in a completely base-paired substrate formed by
hybridizing gluR-B RNA to an antisense transcript.
Taken together, these observations are reminiscent of
early studies of the bacterial dsRNA nuclease, RNase III.
Like dsRAD, RNase III was discovered by its action on
dsRNA and initially characterized using completely
base-paired dsRNA [11]. Once the biological substrates
of RNase III were discovered, it became very clear that
the enzyme is sensitive to various structural elements not
present in the dsRNAs used in its initial characterization
(reviewed in [12]).
Although the three papers report similar observations,
they each also offer distinct insights. For example, while
all the papers demonstrate in vitro editing at the Q/R site,
the one by Melcher et al. [9] also shows that the R/G site
can be edited in vitro. The paper by Rueter et al. [8] is
notable for its demonstration (by cDNA sequencing) that
RNAs edited in vitro, like their endogenous counterparts,
are edited at multiple sites within the proposed double-
stranded regions (see Fig. 1). The observed patterns of
editing look very much like those catalyzed by dsRAD in
vitro on synthetic substrates [13]. Editing hot spots are
observed, and the editing sites occur at adenosines
known to be preferred by dsRAD. For example, consis-
tent with the 5' nearest-neighbor preference of dsRAD
- A = U > C > G - none of the editing hot spots, and
only one of the minor sites, has a 5' guanosine.
Rueter et al. [8] mapped a total of 14 editing sites within
endogenous RNA isolated from rat brain, and found that
in vitro edited transcripts are edited at fewer sites overall,
but the edited sites are a subset of those found in vivo. The
in vitro edited RNAs are reminiscent of the intermediates
observed in the reaction of dsRAD with synthetic sub-
strates, and it seems possible that RNAs edited in vitro
were exposed to less dsRAD, or for shorter lengths of
time, than those edited in vivo. Interestingly, Melcher et al.
[9] mention that only the Q/R and R/G sites were edited
in their in vitro system; this may indicate there were lower
levels of dsRAD in the extracts used by these researchers.
Although dsRAD is clearly present in the crude extracts
used by all three groups, the rigorous individual will note
that dsRAD has not been directly demonstrated to be the
enzyme responsible for the editing, and further, that ino-
sine has not yet been shown to be present within endoge-
nous gluR mRNA. However, given the similarities
between the requirements for gluR RNA editing and the
properties of dsRAD characterized in vitro, it is very hard
to argue that dsRAD is not involved in gluR RNA edit-
ing. In this light, the most important question at present
is not whether dsRAD is involved in this editing event,
but whether it acts alone in vivo, or with accessory factors.
The paper by Yang et al. [7] directly addresses this ques-
tion. These authors biochemically fractionated the crude
nuclear extract they were using on a dsRNA affinity col-
umn, and found that a fraction enriched in gluR--B
RNA editing activity eluted at a higher salt concentra-
tion than the fraction containing the bulk of dsRAD.
Perhaps this fraction contains an alternative form of
dsRAD, with different editing and chromatographic
properties. Alternatively, the fraction may contain dsRAD
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as well as a second factor, or factors, that interact with
dsRAD. Greater than 3M salt is required to elute the
gluR-B-RNA-specific editing activity, indicating that
either the putative factor(s) itself can bind tightly to
dsRNA, or that it interacts with dsRAD to enhance its
affinity for dsRNA.
Proof that additional factors are required for editing gluR
RNA in vivo will require further studies with more puri-
fied systems. However, if one accepts that there are fac-
tors that act in concert with dsRAD in vivo, two possible
roles for these factors can be envisioned. First, endoge-
nous accessory factors could alter the deamination speci-
ficity of dsRAD. As the editing sites that have been
mapped within gluR RNAs are entirely consistent with
the deamination specificity that is intrinsic to dsRAD
[13], at its extreme this hypothesis seems unlikely. The
second hypothesis assumes that the specificity intrinsic to
dsRAD operates in vivo in much the same way that it
does in vitro. In this case, however, requisite accessory
factors would act as chaperones to help dsRAD substrates
assume the structure that allows the intrinsic specificity of
dsRAD to produce the editing events observed in vivo. If
the latter scenario holds true, it may be possible to find in
vitro conditions that promote the correct structure of
gluR RNAs so that dsRAD could act alone.
Regardless, it is certainly an interesting time for studies
of both gluR RNA editing and dsRAD. The enzyme
dsRAD has now been purified from several organisms,
and several mammalian cDNAs have been cloned
[14,15]. These reagents should facilitate the identification
of the putative accessory factors required for gluR RNA
editing, as well as more in-depth studies of the role of
editing in modulating gluR function. Laboratories long
involved in studies of dsRAD using synthetic substrates
will no doubt gain additional insight by characterizing
the enzymes using biological substrates.
So far, editing of metazoan RNAs has only been
observed in mammals. The enzyme dsRAD is wide-
spread among metazoans, suggesting that other examples
of editing in metazoans exist. In addition, as pointed out
by Melcher et al. [9], dsRAD is present in mammalian
cells that do not express gluR genes, suggesting that
other dsRAD substrates exist in mammals. Finally, an
obvious question is whether dsRAD is primarily an
RNA-editing enzyme or has another, as yet undeter-
mined, biological function. Given the multiple editing
sites mapped within gluR RNAs that have no obvious
function (see Fig. 1), it seems likely that dsRAD was co-
opted as an editing enzyme from another aspect of RNA
metabolism. Until further notice, it seems prudent for
scientists studying nuclear encoded RNAs to adopt the
cautious approach in regard to cDNA sequences long
held by those studying organelle-encoded RNAs.
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